Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons and usually results in death within 2-5 years of symptom onset. Researchers used nuclear magnetic resonance (NMR) spectroscopy to analyze cerebral spinal fluid (CSF) samples from ALS patients and controls to search for biomarkers in early ALS. The study found that NMR spectroscopy, when combined with other analytical techniques, could detect changes in certain CSF metabolite concentrations for ALS patients. However, the mechanisms of ALS are complex and no single biomarker has been identified that could replace regular patient checkups.